Your Article Summary
See Latest ArticlesGene- and Viral-Based Therapies for Brain Tumors
Neurotherapeutics, 07/01/09
Asadi-Moghaddam K et al. - Advances in understanding and controlling genes and their expression have set the stage to alter genetic material to fight or prevent disease with brain tumors being among one of the first human malignancies to be targeted by gene therapy. All proteins are coded for by DNA and most neoplastic diseases ultimately result from the expression or lack thereof with one or more proteins.
Related Articles
Issues in postmenopausal hormone therapy: A 3-part CME newsletter series Counseling patients about bioidentical hormone preparations
Sexuality, Reproduction & Menopause, 11/13/09
Relevance Score: 47%
Issues in postmenopausal hormone therapy: depression, endometrial health, and discontinuation
Sexuality, Reproduction & Menopause, 10/09/09
Relevance Score: 47%
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09
Relevance Score: 46%
A New Era in Iron Chelation Therapy: The Design of Optimal, Individually Adjusted Iron Chelation Therapies for the Complete Removal of Iron Overload in Thalassemia and other Chronically Transfused Patients
Hemoglobin, 10/23/09
Relevance Score: 46%
Sonodynamic and Photodynamic Therapy in Advanced Breast Carcinoma: A Report of 3 Cases
Integrative Cancer Therapies, 10/13/09
Relevance Score: 46%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
DO Intracranial Neoplasms Differ in Ollier Disease and Maffucci Syndrome? An in-Depth Analysis of the Literature
Neurosurgery, 12/07/09
Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
Journal of Neuro-Oncology, 12/07/09
High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system
Journal of Neuro-Oncology, 12/07/09